Methylation landscape of human breast cancer cells in response to dietary compound resveratrol

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Medina Aguilar, Rubiceli ^a   Pérez Plasencia, Carlos ^b   Marchat, Laurence A ^c   Gariglio, Patricio ^a   García Mena, Jaime ^a   Rodríguez Cuevas, Sergio ^d   Ruíz García, Erika ^e   Astudillo De La Vega, Horacio ^f   Hernández Juárez, Jennifer ^a   Flores Pérez, Ali ^g   López Camarillo, César ^g  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^d Instituto de Enfermedades de la Mama   (Mexico)

^e INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^f HOSPITAL DE ONCOLOGÍA   (Mexico)

^g UNIVERSIDAD AUTÓNOMA DE LA CIUDAD DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RESVERATROL; TRANSCRIPTOME; ANTINEOPLASTIC AGENT; STILBENE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER CELL LINE; CONTROLLED STUDY; CPG ISLAND; DIETARY INTAKE; DNA METHYLATION; DRUG TARGETING; EPIGENETICS; GENE LOCUS; GENE THERAPY; GENETIC ANALYSIS; HUMAN; HUMAN CELL; ONCOGENE; PROMOTER REGION; PROTEIN EXPRESSION; TIME; TRIPLE NEGATIVE BREAST CANCER; TUMOR SUPPRESSOR GENE; BREAST NEOPLASMS; DNA MICROARRAY; FEMALE; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; GENOME-WIDE ASSOCIATION STUDY; TUMOR CELL LINE;

ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME-WIDE ASSOCIATION STUDY; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; STILBENES;

EID: 84977536144     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0157866     Document Type: Article

References (38)

1. Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM. The global burden of cancer: priorities for prevention. Carcinogenesis. 2010; 31:100-110. doi: 10.1093/carcin/bgp263 PMID: 19934210
2. Stefanska B, Huang J, Bhattacharyya B, Suderman M, Hallett M, Han ZG, Szyf M. Definition of the landscape of promoter DNA hypomethylation in liver cancer. Cancer research. 2011; 71(17), 5891-5903. doi: 10.1158/0008-5472.CAN-10-3823 PMID: 21747116
3. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer-a mechanism for early oncogenic pathway addiction? Nat Rev Cancer. 2006; 6:107-116. doi: 10.1038/nrc1799 PMID: 16491070
4. Ong TP, Moreno FS, Ross SA. Targeting the epigenome with bioactive food components for cancer prevention. J Nutrigenet Nutrigenomics. 2011; 5: 275-92. doi: 10.1159/000334585 PMID: 22353664
5. Ross SA, Dwyer J, Umar A, Kagan J, Verma M, Van Bemmel DM, et al. Introduction: diet, epigenetic events and cancer prevention. Nutrition reviews. 2008; 66 (suppl 1) S1-S6.
6. Thakur VS, Deb G, Babcook MA, Gupta S. Plant Phytochemicals as Epigenetic Modulators: Role in Cancer Chemoprevention. The AAPS Journal. 2014; 16:151-163. doi: 10.1208/s12248-013-9548-5 PMID: 24307610
7. Whitlock NC, Baek SJ. The anticancer effects of resveratrol: Modulation of transcription factors. Nutrition and Cancer. 2012; 64:493-502.2012 doi: 10.1080/01635581.2012.667862 PMID: 22482424
8. Paluszczak J, Krajka KV, Baer W. The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells. Toxicol Lett. 2010; 192 (2):119-125. doi: 10.1016/j.toxlet.2009 PMID: 19840838
9. Papoutsis AJ, Lamore SD, Wondrak GT, Selmin OI, Romagnolo DF. Resveratrol prevents epigenetic silencing of BRCA-1 by the aromatic hydrocarbon receptor in human breast cancer cells. J Nutr. 2010; 140:1607-14. doi: 10.3945/jn.110.123422 PMID: 20631324
10. Phuah NH, Nagoor NH. Regulation of MicroRNAs by Natural Agents: New Strategies in Cancer Therapies. BioMed Res. 2014:804510. doi: 10.1155/2014/804510 PMID: 25254214
11. Chia YL, Wei CH, Duncan EW, Chia LH, Yi CL, Guoo SW, et al. Resveratrol activates the histone H2B ubiquitin ligase, RNF20 in MDA-MB-231 breast cancer cells. J Funct Foods. 2013; 5:790-800. doi: 10.1016/j.jff.2013.01.025
12. Pfister S, Schlaeger C, Mendrzyk F, Wittmann A, Benner A, Kulozik A, Scheurlen W, et al. Array-based profiling of reference-independent methylation status (aPRIMES) identifies frequent promoter methylation and consecutive downregulation of ZIC2 in pediatric medulloblastoma. Nucleic Acids Res. 2007; 35:e51. PMID: 17344319
13. Morris MR, Ricketts CJ, Gentle D, McRonald F, Carli N, Khalili H, et al. Genome-wide methylation analysis identifies epigenetically inactivated candidate tumor suppressor genes in renal cell carcinoma. Oncogene. 2011; 24; 30(12):1390-401. doi: 10.1038/onc.2010.525 PMID: 21132003
14. Xiang TX, Yuan Y, Li LL, Wang ZH, Dan LY, Chen Y, et al. Aberrant promoter CpG methylation and its translational applications in breast cancer. Chin J Cancer. 2013; 32(1):12-20. doi: 10.5732/cjc.011.10344 PMID: 22059908
15. Esteller M. Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet. 2007; 16: R50-R59. PMID: 17613547
16. Udali S, Guarini P, Ruzzenente A, Ferrarini A, Guglielmi A, Lotto V, et al. DNA methylation and gene expression profiles show novel regulatory pathways in hepatocellular carcinoma. Clin Epigenetics. 2015; 7(1):43. doi: 10.1186/s13148-015-0077-1 PMID: 25945129
17. Fanale D, Bazan V, Corsini LR, Caruso S, Insalaco L, et al. HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions. Breast Cancer Res Treat. 2013; 140(3), 505-517. doi: 10.1007/s10549-013-2649-0 PMID: 23925655
18. Chae SW, Sohn JH, Kim D-H, Choi YJ, Park YL, Kim K, et al. Overexpressions of Cyclin B1, cdc2, p16 and p53 in Human Breast Cancer: The Clinicopathologic Correlations and Prognostic Implications. Yonsei Med J. 2011; 52(3):445-453. doi: 10.3349/ymj.2011.52.3.445 PMID: 21488187
19. Wolf A, Agnihotri S, Micallef J, Mukherjee J, Sabha N, et al. Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. J Exp Med. 2011; 208(2), 313-326. http://doi.org/10.1084/jem.20101470. PMID: 21242296 doi: 10.1084/jem.20101470
20. Brait M, Ling S, Nagpal JK, Chang X, Park HL, Lee J, et al. Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers. PLoS One. 2012; 7(9):e44951. doi: 10.1371/journal.pone.0044951 PMID: 23028699
21. Chimonidou M, Strati A, Tzitzira A, Sotiropoulou G, Malamos N, Georgoulias V, et al. DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells. Clin Chem. 2011; 57(8):1169-77. doi: 10.1373/clinchem.2011.165902 PMID: 21700955
22. Dickinson RE, Dallol A, Bieche I, Krex D, Morton D, Maher ER, et al. Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers. Br J Cancer. 2004; 13; 91(12):2071-8. doi: 10.1373/clinchem.2011.165902 PMID: 15534609
23. Adriaens ME, Jaillard M, Eijssen L, Mayer CD, Evelo, C. An evaluation of two-channel ChIP-on-chip and DNA methylation microarray normalization strategies. BMC Genomics. 2012; 13:42. doi: 10.1186/1471-2164-13-42 PMID: 22276688
24. Medina A. Gariglio P, Garcia MJ, Arechaga OE, Villegas SN, Martínez CM, et al. Resveratrol inhibits cell cycle by targeting Aurora kinase A and Polo Like Kinase 1 in breast cancer cells. Oncology Reports. 2016;
25. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International journal of cancer. 2015; 136(5), E359-E386. doi: 10.1002/ijc.29210 PMID: 25220842
26. Colin D, Limagne E, Jeanningros S, Jacquel A, Lizard G, Athias A, et al. Endocytosis of resveratrol via lipid rafts and activation of downstream signaling pathways in cancer cells. Cancer Prevention Research. 2011; 4(7), 1095-1106. doi: 10.1158/1940-6207.CAPR-10-0274 PMID: 21467134
27. Li D, Bi FF, Cao JM, Cao C, Liu B, Yang Q. Regulation of DNA methyltransferase 1 transcription in BRCA1-mutated breast cancer: a novel crosstalk between E2F1 motif hypermethylation and loss of histone H3 lysine 9 acetylation. Mol Cancer. 2014; 13:26. doi: 10.1186/1476-4598-13-26 PMID: 24502362
28. Dhar S, Kumar A, Li K, Tzivion G, Levenson AS. Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer. Biochim Biophys Acta. 2015; 1853(2):265-75. doi: 10.1016/j.bbamcr.2014.11.004 Epub 2014 Nov 13. PMID: 25447541
29. Gao Z, Xu MS, Barnett TL, Xu CW. Resveratrol induces cellular senescence with attenuated mono-ubiquitination of histone H2B in glioma cells. Biochem Biophys Res Commun. 2011; 8: 271-6. doi: 10.1016/j.bbrc.2011.02.008 PMID: 21481687
30. Link A, Balaguer F, Shen Y, Lozano JJ, Leung HC, Boland CR, et al. Curcumin modulates DNA methylation in colorectal cancer cells. PLoS One. 2013; 8(2), e57709. doi: 10.1371/journal.pone.0057709 PMID: 23460897
31. Huang V, Place RF, Portnoy V, Wang J, Qi Z, Jia Z, Yu A, et al. Upregulation of Cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Research. 2012; 40(4), 1695-1707. http://doi.org/10.1093/nar/gkr934. PMID: 22053081 doi: 10.1093/nar/gkr934
32. Ou Y, Ma L, Ma L, Huang Z, Zhou W, et al. Overexpression of cyclin B1 antagonizes chemotherapeutic-induced apoptosis through PTEN/Akt pathway in human esophageal squamous cell carcinoma cells. Cancer Biol Ther. 2013; 14(1), 45-55. http://doi.org/10.4161/cbt.22627. PMID: 23114644 doi: 10.4161/cbt.22627
33. Bustamante E, Morris HP, Pedersen PL. Energy metabolism of tumor cells. Requirement for a form of hexokinase with a propensity for mitochondrial binding. J Biol Chem. 1981; 256:8699-870. PMID: 7263678
34. Dai W, Wang F, Lu J, Xia Y, He L, Chen K, et al. By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice. Oncotarget. 2015; 6(15): 13703-13717. doi: 10.18632/oncotarget.3800 PMID: 25938543
35. Zhang B, Dietrich UM, Geng J-G, Bicknell R, Esko JD, Wang L. Repulsive axon guidance molecule Slit3 is a novel angiogenic factor. Blood. 2009; 114(19), 4300-4309. PMID: 19741192 doi: 10.1182/blood-2008-12-193326
36. Fu D, Ren C, Tan H, Wei J, Zhu Y, et al. Sox17 Promoter Methylation in Plasma DNA Is Associated With Poor Survival and Can Be Used as a Prognostic Factor in Breast Cancer. Medicine. 2015; 94(11), e637. PMID: 25789956 doi: 10.1097/MD.0000000000000637
37. Dickinson RE, Fegan KS, Ren X, Hillier SG, Duncan WC. Glucocorticoid regulation of SLIT/ROBO tumor suppressor genes in the ovarian surface epithelium and ovarian cancer cells. PLoS One. 2011; 6: e27792. doi: 10.1371/journal.pone.0027792 PMID: 22132142
38. Minatani N, Waraya M, Yamashita K, Kikuchi M, Ushiku H, Kojo K, et al. Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer. PLoS One. 2016; 11(1):e0144862. doi: 10.1371/journal.pone.0144862 PMID: 26785325